Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma
Lackman, M. H.; Wardell, C.; Darrigues, E.; De Loose, A.; Lyle, G. A.; Xue, Y.; Learned, K.; Cheney, A.; Vaske, O. M.; Karaman, S.; Le Joncour, V. J.; Rodriguez, A.
Show abstract
Linking glioblastoma (GBM) evolution to clinical progression is challenged by multiple factors, including tumor location for repeated sample collection, and short patient survival. In a single individual, we collected and analysed samples from 11 operations distributed across 31 months of multi-relapsing and multifocal GBM, including terminal leptomeningeal progression. All samples shared genomic ancestry of the retinoblastoma protein 1 (RB1) and neurofibromin 1 (NF1) mutations while advanced progression and extracranial metastases featured mutations of tuberous sclerosis complex 2 (TSC2), PBRM1, CD22 and Fanconi anemia supplementation group I (FANCI), correlated with clinical resistance to immunotherapies and DNA-damaging agents. Single-cell analytics revealed distinct yet reversible shifts in response to the precision medicine arsenal. GBM parenchymal dissemination and extracranial progression were associated with strengthening of neuron-like cell phenotypes. Our multidimensional study describes GBM evolution over a rarely reported time scale, and provides a valuable resource linking genetic, molecular, cellular and clinical progressions.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence 97%
- Single-cell landscapes of primary glioblastomas and matched organoids and cell lines reveal variable retention of inter- and intra-tumor heterogeneity 96%
- Advancing CNS tumor diagnostics with expanded DNA methylation-based classification 96%
Similar papers in this journal
- Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma 96%
- Purine metabolism regulates DNA repair and therapy resistance in glioblastoma 96%
- Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations 96%
Similar papers in this journal
- Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome 95%
- Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer 94%
- Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up 94%
Similar papers in this journal
- Single-Cell Spatial Proteomics Analyses of Head and Neck Squamous Cell Carcinoma Reveal Tumor Heterogeneity and Immune Architectures Associated with Clinical Outcome 95%
- A single-cell based precision medicine approach using glioblastoma patient-specific models 95%
- Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images 94%
Similar papers in this journal
- Spatial profiling of longitudinal glioblastoma reveals consistent changes in cellular architecture, post-treatment 97%
- Pyruvate carboxylation identifies Glioblastoma Stem-like Cells opening new metabolic strategy to prevent tumor recurrence 96%
- Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastoma 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.